Literature DB >> 6980906

Enumeration of T cell subsets in atopic dermatitis using monoclonal antibodies.

D Y Leung, A R Rhodes, R S Geha.   

Abstract

Peripheral blood lymphocytes from 22 patients with atopic dermatitis, 17 age-matched healthy controls, 10 patients with other skin diseases, and 14 patients with either asthma or allergic rhinitis were characterized by reactivity with monoclonal antibodies to the surface antigens of helper-inducer (T4) and suppressor-cytotoxic (T8) T cell subsets and to a common T cell antigen (T3). In contrast to healthy controls and controls with other skin diseases or respiratory allergic disease, patients with atopic dermatitis had a reduced percentage of T3-positive (T3+)cells (p less than 0.01) and T8-positive (T8+) cells (p less than 0.001) but not of T4-positive cells (T4+)op less than 0.05). A selective increase in the ratio of T4+ cells over T8+ cells was observed in 17 of 22 patients with atopic dermatitis but not in any of the controls. Thus there is a loss of circulating suppressor-cytoxic T cells in the majority of patients with active atopic dermatitis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6980906     DOI: 10.1016/0091-6749(81)90098-1

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  20 in total

Review 1.  Prediction of the development of IgE-mediated atopic disorders and environmental engineering for their control.

Authors:  B A Chowdhury; R K Chandra
Journal:  Clin Rev Allergy       Date:  1989

2.  In vivo and in vitro effects of glucocorticoids on lectin-induced blastogenesis in atopic dermatitis.

Authors:  M Rupprecht; R Rupprecht; N Wodarz; H U Braner; J Kornhuber; H U Koch; P Riederer; O P Hornstein
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

3.  Decreased monocyte production of interleukin-1 and impaired lymphocyte proliferation in atopic dermatitis.

Authors:  L Räsänen; M Lehto; T Reunala; C Jansen; P Leinikki
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

Review 4.  Immunoregulatory abnormalities in atopic dermatitis.

Authors:  D Y Leung; R S Geha
Journal:  Clin Rev Allergy       Date:  1986-02

Review 5.  Control of IgE synthesis in man.

Authors:  D Y Leung; R S Geha
Journal:  J Clin Immunol       Date:  1986-07       Impact factor: 8.317

6.  Interleukin 2 therapy in severe atopic dermatitis.

Authors:  K H Hsieh; C C Chou; S F Huang
Journal:  J Clin Immunol       Date:  1991-01       Impact factor: 8.317

7.  IgE Fc receptor positive T and B lymphocytes in patients with the hyper IgE syndrome.

Authors:  L F Thompson; H L Spiegelberg; R H Buckley
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

8.  Impairment of the autologous mixed lymphocyte reaction in atopic dermatitis.

Authors:  D Y Leung; J A Saryan; R Frankel; M Lareau; R S Geha
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

9.  Natural killer cell activity in atopic dermatitis.

Authors:  M Viander; J Uksila; O Lassila; C T Jansén
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

10.  Humoral and cellular immune response of the rat to immunization with bee venom.

Authors:  H Schneider; R Urbanek
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.